Limberg flap reconstruction for recurrent pilonidal sinus disease: A single-center U.S. Cohort - Summary - MDSpire

Limberg flap reconstruction for recurrent pilonidal sinus disease: A single-center U.S. Cohort

  • By

  • Mustafa Oruc

  • Joshua Sommovilla

  • Salih Karahan

  • Joseph Trunzo

  • Metincan Erkaya

  • Michael Valente

  • Emre Gorgun

  • February 12, 2026

  • 0 min

Share

Objective:

To evaluate the long-term outcomes of Limberg flap reconstruction in patients with recurrent pilonidal sinus disease at a single U.S. center.

Key Findings:
  • Thirty-seven patients were included, predominantly male (76%) with a median BMI of 29.4 kg/m².
  • 59% of patients were active smokers and 52% had multiple previous pilonidal operations.
  • The median operative time was 72 minutes, with 92% discharged on the same day and no surgical drains used.
  • Postoperative complication rate was 11%, primarily wound dehiscence.
  • No recurrence was observed during the median follow-up of 4.5 years.
Interpretation:

Limberg flap reconstruction for recurrent pilonidal sinus disease demonstrated durable disease control and acceptable morbidity, supporting its use in complex cases.

Limitations:
  • Retrospective design may introduce bias.
  • Limited generalizability due to single-center study.
  • Data sharing is restricted due to patient privacy and ethical considerations.
Conclusion:

Limberg flap reconstruction is a viable surgical option for patients with recurrent pilonidal sinus disease, offering effective long-term outcomes.

Original Source(s)

Related Content